SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-20-003130
Filing Date
2020-03-24
Accepted
2020-03-24 07:53:18
Documents
14
Period of Report
2020-03-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT txmd-8k_032020.htm   iXBRL 8-K 38199
2 PRESS RELEASE ex99-1.htm EX-99.1 17334
3 GRAPHIC txmd_logo.jpg GRAPHIC 21678
  Complete submission text file 0001387131-20-003130.txt   272802

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT txmd-20200320.xsd EX-101.SCH 3204
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT txmd-20200320_pre.xml EX-101.PRE 23158
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT txmd-20200320_lab.xml EX-101.LAB 35273
14 EXTRACTED XBRL INSTANCE DOCUMENT txmd-8k_032020_htm.xml XML 3767
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 20736629
SIC: 2834 Pharmaceutical Preparations